2 more die of COVID-19 complications in Olongapo | Inquirer News

2 more die of COVID-19 complications in Olongapo

Two more patients here died of COVID-19 complications, raising to 341 the city's total death toll related to the viral disease, local data showed on Thursday, Feb. 10.

The number of active COVID-19 cases in Olongapo City has dropped to 123 as of Thursday, Feb. 10, as more patients recover from the viral disease. (Photo by Joanna Rose Aglibot)

OLONGAPO CITY — Two more patients here died of COVID-19 complications, raising to 341 the city’s total death toll related to the viral disease, local data showed on Thursday, Feb. 10.

According to the city’s COVID-19 task force, the latest fatalities were both women ages 51 and 52.

ADVERTISEMENT

The 51-year-old patient succumbed to cardiac arrest secondary to diabetes mellitus while the 52-year-old woman suffered from acute coronary syndrome, subarachnoid hemorrhage and pneumonia.

FEATURED STORIES

Despite this, the number of new COVID-19 cases in the city further dropped to 123 after logging 65 new recoveries and six new cases on Thursday.

The new patients are ages 30 to 65 and were all fully vaccinated.

So far, the city has already recorded 6,923 confirmed COVID-19 cases with 6,459 recoveries.

RELATED STORY:

Active COVID-19 cases in Olongapo fall below 100-mark

JPV
Your subscription could not be saved. Please try again.
Your subscription has been successful.

Subscribe to our daily newsletter

By providing an email address. I agree to the Terms of Use and acknowledge that I have read the Privacy Policy.

For more news about the novel coronavirus click here.
What you need to know about Coronavirus.
For more information on COVID-19, call the DOH Hotline: (02) 86517800 local 1149/1150.

The Inquirer Foundation supports our healthcare frontliners and is still accepting cash donations to be deposited at Banco de Oro (BDO) current account #007960018860 or donate through PayMaya using this link.

TAGS: COVID-19, Olongapo

© Copyright 1997-2024 INQUIRER.net | All Rights Reserved

We use cookies to ensure you get the best experience on our website. By continuing, you are agreeing to our use of cookies. To find out more, please click this link.